Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 91 AL 105

Neuronal Death and Biomolecular Condensates: Are There Any New Treatment Options for Alzheimer's Disease?

Kochman U, Sitka H, Kuźniar J, Czaja M, Kozubek P, Beszłej JA, Leszek J.

Cells. 2025 Aug 30;14(17):1356. doi: 10.3390/cells14171356.

The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil

Vasincu A, Rusu RN, Ababei DC, Bulea D, Arcan OD, Vasincu IM, Beșchea Chiriac S, Popescu IR, Bild W, Bild V.

Nutrients. 2025 Sep 5;17(17):2877. doi: 10.3390/nu17172877.

Decoding the neuroprotective potential of hesperidin: Insights into Alzheimer's disease

Chauhan P, Vadia N, Ballal S, Joshi KK, Maharana L, Chauhan AS, Abomughaid MM, Lakhanpal S, Avinash D, Thakur K, Gupta R, Wadhwa K, Singh G, Jha NK.

Neuroscience. 2025 Nov 28;589:205-220. doi: 10.1016/j.neuroscience.2025.09.028. Epub 2025 Sep 20.

Treatment for Alzheimer's disease

Fox NC, Belder C, Ballard C, Kales HC, Mummery C, Caramelli P, Ciccarelli O, Frederiksen KS, Gomez-Isla T, Ismail Z, Paquet C, Petersen RC, Perneczky R, Robinson L, Sayin O, Frisoni GB.

Lancet. 2025 Sep 27;406(10510):1408-1423. doi: 10.1016/S0140-6736(25)01329-7. Epub 2025 Sep 22.

Alzheimer's disease outlook: controversies and future directions

Frisoni GB, Aho E, Brayne C, Ciccarelli O, Dubois B, Fox NC, Frederiksen KS, Gabay C, Garibotto V, Hofmarcher T, Jack CR Jr, Kivipelto M, Petersen RC, Ribaldi F, Rowe CC, Walsh S, Zetterberg H, Hansson O.

Lancet. 2025 Sep 27;406(10510):1424-1442. doi: 10.1016/S0140-6736(25)01389-3. Epub 2025 Sep 22.

Targeting the awry Aβ pathway in Alzheimer's disease: hype and hurdles

Al-Kuraishy HM, Sulaiman GM, Al-Gareeb AI, Mohammed HA, Albuhadily AK, Abomughaid MM.

Inflammopharmacology. 2025 Oct;33(10):5945-5961. doi: 10.1007/s10787-025-01983-9. Epub 2025 Sep 27.

Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers

Schreiber CP, Kovacik A, Bishop J, Helman J.

Drugs Aging. 2025 Dec;42(12):1103-1111. doi: 10.1007/s40266-025-01253-x. Epub 2025 Oct 3.

TDP-43 in Alzheimer's disease: Pathophysiology and therapeutic strategies

Zhou X, Lin X, He Y, Huang N, Luo Y.

Pharmacol Res. 2025 Nov;221:107977. doi: 10.1016/j.phrs.2025.107977. Epub 2025 Oct 4.

Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer's disease

Fan X, Wang H, Ping J, Li M, Gu J, Qian W.

Biochem Pharmacol. 2025 Dec;242(Pt 3):117401. doi: 10.1016/j.bcp.2025.117401. Epub 2025 Oct 3.

Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer's disease

Amniouel S, Suh J, Zheng W, Zhang Q.

Transl Neurodegener. 2025 Oct 13;14(1):51. doi: 10.1186/s40035-025-00513-5.

Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead

Papaliagkas V.

Int J Mol Sci. 2025 Sep 29;26(19):9529. doi: 10.3390/ijms26199529.

[Significance of Amyloid Plaque Removal in Alzheimer's Disease Treatment: Development of Amyloid β-Targeting Antibody Drugs Based on the Amyloid Cascade Hypothesis]

Kowa H, Sato S, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Oct;77(10):1129-1136. doi: 10.11477/mf.188160960770101129.

Alzheimer Combination Therapies: Overview and Scenarios

Cummings JL, Burstein AH, Fillit H.

J Prev Alzheimers Dis. 2025 Dec;12(10):100328. doi: 10.1016/j.tjpad.2025.100328. Epub 2025 Oct 27.

Add-on combination therapy with monoclonal antibodies: Implications for drug development

Cummings J, Burstein AH, Fillit H.

J Prev Alzheimers Dis. 2025 Dec;12(10):100359. doi: 10.1016/j.tjpad.2025.100359. Epub 2025 Oct 27.

APOE-Targeted Therapeutics for Alzheimer's Disease

Yassine HN, Hugo C, O'Donovan B, Stephens IO, Johnson LA, Cole G, Tcw J, Johansson J, Kisler K, Chiba-Falek O.

J Neurosci. 2025 Nov 12;45(46):e1388252025. doi: 10.1523/JNEUROSCI.1388-25.2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias